BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced that Howard Holden, Ph.D., has joined the Company as Vice President of Regulatory Affairs and Quality Assurance. With over 25 years of experience in regulatory affairs and compliance in the pharmaceutical / biotechnology industry, Dr. Holden will lead regulatory affairs and quality assurance for Array's pipeline of targeted small molecule drugs to treat cancer and inflammatory diseases.
